Showing results (261-270 of 334) with videos related to
Sort By:
Pageof 34
Thrombosis and Haemostasis|February 26, 2021
Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19Stefanie Hammer, Helene Häberle, Christian Schlensak, et al.Oncoimmunology|February 1, 2020
GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cellsChristian M Seitz, Sarah Schroeder, Philipp Knopf, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2021
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infectionsTanja A Stief, Theresa Kaeuferle, Thomas R Müller, et al.Frontiers in Immunology|December 24, 2024
Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture systemChristina Völzke, Lisa Ehrhardt, Laura Fischer, et al.Experimental Hematology|June 20, 2007
A novel approach for the analysis of T-cell reconstitution by using a T-cell receptor beta-based oligonucleotide microarray in hematopoietic stem cell transplantationXiaohua Chen, Gregory A Hale, Geoffrey A M Neale, et al.Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.Bone Marrow Transplantation|August 22, 2019
ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALLPatrick Schlegel, Gundram Jung, Anne-Marie Lang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study GroupPeter Bader, Hermann Kreyenberg, Günter H R Henze, et al.Frontiers in Oncology|March 10, 2023
Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomasThomas Eichholz, Michaela Döring, Stefano Giardino, et al.Theranostics|February 7, 2024
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-NOTA-ch14.18/CHONils Florian Trautwein, Johannes Schwenck, Christian Seitz, et al.Pageof 34